HTHT
CVS icon

Hemenway Trust Hemenway Trust’s CVS Health CVS Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Sell
3,013
-40
-1% -$3.08K 0.02% 127
2025
Q4 		$242K Sell
3,053
-100
-3% -$7.88K 0.02% 115
2025
Q3 		$238K Hold
3,153
– – 0.02% 118
2025
Q2 		$217K Sell
3,153
-775
-20% -$50.8K 0.02% 118
2025
Q1 		$266K Sell
3,928
-1,900
-33% -$114K 0.02% 106
2024
Q4 		$262K Sell
5,828
-1,346
-19% -$75.5K 0.02% 107
2024
Q3 		$451K Sell
7,174
-18,512
-72% -$1.08M 0.04% 88
2024
Q2 		$1.52M Sell
25,686
-47,604
-65% -$2.98M 0.13% 54
2024
Q1 		$5.85M Sell
73,290
-40,393
-36% -$3.09M 0.51% 37
2023
Q4 		$8.98M Sell
113,683
-32,348
-22% -$2.3M 0.86% 32
2023
Q3 		$10.2M Sell
146,031
-27,016
-16% -$1.91M 1.07% 29
2023
Q2 		$12M Sell
173,047
-1,642
-0.9% -$117K 1.17% 30
2023
Q1 		$13M Sell
174,689
-1,048
-0.6% -$87.9K 1.38% 29
2022
Q4 		$16.4M Sell
175,737
-8,543
-5% -$824K 1.82% 25
2022
Q3 		$17.6M Buy
184,280
+2,246
+1% +$222K 2.06% 21
2022
Q2 		$16.9M Sell
182,034
-6,093
-3% -$595K 1.92% 21
2022
Q1 		$19M Buy
188,127
+3,669
+2% +$385K 1.83% 22
2021
Q4 		$19M Buy
184,458
+1,745
+1% +$161K 1.73% 27
2021
Q3 		$15.5M Buy
182,713
+2,135
+1% +$179K 1.57% 31
2021
Q2 		$15.1M Buy
180,578
+4,843
+3% +$397K 1.52% 30
2021
Q1 		$13.2M Buy
175,735
+8,696
+5% +$633K 1.45% 30
2020
Q4 		$11.4M Buy
167,039
+10,553
+7% +$686K 1.31% 31
2020
Q3 		$9.14M Buy
156,486
+3,446
+2% +$214K 1.19% 33
2020
Q2 		$9.94M Buy
153,040
+2,970
+2% +$187K 1.38% 30
2020
Q1 		$8.9M Buy
150,070
+7,362
+5% +$491K 1.51% 31
2019
Q4 		$10.6M Buy
142,708
+1,426
+1% +$100K 1.52% 31
2019
Q3 		$8.91M Sell
141,282
-5,563
-4% -$330K 1.4% 31
2019
Q2 		$8M Sell
146,845
-256
-0.2% -$13.8K 1.24% 32
2019
Q1 		$7.93M Buy
147,101
+9,436
+7% +$582K 1.28% 31
2018
Q4 		$9.02M Sell
137,665
-10,238
-7% -$764K 1.84% 24
2018
Q3 		$11.6M Sell
147,903
-5,728
-4% -$410K 1.96% 23
2018
Q2 		$9.89M Buy
153,631
+546
+0.4% +$36K 1.82% 23
2018
Q1 		$9.52M Sell
153,085
-2,065
-1% -$148K 1.81% 25
2017
Q4 		$11.2M Sell
155,150
-1,064
-0.7% -$77.4K 2.14% 19
2017
Q3 		$12.7M Buy
156,214
+2,351
+2% +$186K 2.65% 15
2017
Q2 		$12.4M Buy
153,863
+3,292
+2% +$260K 2.75% 13
2017
Q1 		$11.8M Buy
150,571
+2,221
+1% +$177K 2.72% 11
2016
Q4 		$11.7M Buy
148,350
+651
+0.4% +$52.7K 2.95% 9
2016
Q3 		$13.1M Buy
147,699
+4,363
+3% +$412K 3.29% 6
2016
Q2 		$13.7M Buy
143,336
+1,910
+1% +$190K 3.58% 2
2016
Q1 		$14.7M Buy
141,426
+25
+0% +$2.43K 3.96% 1
2015
Q4 		$13.8M Buy
141,401
+1,680
+1% +$165K 3.65% 2
2015
Q3 		$13.5M Buy
139,721
+3,395
+2% +$357K 3.72% 1
2015
Q2 		$14.3M Buy
136,326
+4,560
+3% +$466K 3.67% 1
2015
Q1 		$13.6M Sell
131,766
-5,685
-4% -$575K 3.56% 1
2014
Q4 		$13.2M Buy
137,451
+1,827
+1% +$161K 3.96% 1
2014
Q3 		$10.8M Sell
135,624
-5,673
-4% -$447K 3.38% 1
2014
Q2 		$10.7M Sell
141,297
-11,819
-8% -$893K 3.23% 1
2014
Q1 		$11.5M Buy
153,116
+1,741
+1% +$123K 3.61% 1
2013
Q4 		$10.8M Buy
151,375
+1,470
+1% +$94.5K 3.47% 2
2013
Q3 		$8.51M Buy
149,905
+2,075
+1% +$124K 3.17% 2
2013
Q2 		$8.45M Buy
+147,830
New +$8.56M 3.6% 1

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hemenway Trust Hemenway Trust's CVS Position: Q1 2026 in Review

Hemenway Trust Hemenway Trust reduced its CVS Health (CVS) stake by 1.3% in Q1 2026, selling an estimated $3.08K and leaving 3,013 shares worth $216K. The position accounts for 0.02% of the portfolio, ranked #127.

Hemenway Trust Hemenway Trust first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $19M in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Hemenway Trust Hemenway Trust held 3,013 shares of CVS Health worth $216K as of Q1 2026.
  • Hemenway Trust Hemenway Trust sold 40 CVS Health shares in Q1 2026, an estimated $3.08K.
  • CVS Health made up 0.02% of Hemenway Trust Hemenway Trust's portfolio in Q1 2026, its #127 holding.
  • Hemenway Trust Hemenway Trust first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Hemenway Trust Hemenway Trust's CVS Health position peaked at $19M in Q1 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2026, filed 7 May 2026.